Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
BMS-986315 is a monoclonal antibody that binds to NKG2A and prevents its interaction with HLA-E, which may lead to cytotoxic immune response against tumor cells (NCI Thesaurus).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BMS-986315 + Cetuximab||BMS-986315 Cetuximab||0||1|
|BMS-986315 + Nivolumab||BMS-986315 Nivolumab||0||1|